Home
About SUPPORT+
Equip Yourself
I've just been told I have cancer...
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Stomach Cancer
Uterine Cancer
Skin Cancer
Thyroid Cancer
Lymphoma
Pancreatic Cancer
Oesophageal Cancer
Nasopharyngeal Carcinoma
Cervical Cancer
Ovarian Cancer
Kidney Cancer
Brain Metastasis
Bone Metastasis
Intestinal Obstruction
Malignant Spinal Cord Compression
Older People with Cancer
Adolescents and Young Adults with Cancer
Let's walk together
Overview
Physical
Psychological
Social
Spiritual
Cherish every moment; love every day.
Overview
Will Setting
Life Insurance
Funeral and Burial Arrangement
Organ and Body Donations
Enduring Powers of Attorney
Advance Care Planning
Advance Directive
DNACPR
Die-at-home Arrangement
The Last Few Days
Facing Loss
Let's take a break!
Acupressure
Breathing Exercises
Meditation
Home Exercises
Drawing
Music Therapy
Aromatherapy
Sachets DIY
A Simple Hug
Tips and Resources
Community Resources
Patient Support Programmes
Diet & Cancer
Caring Tips
Sharing & Support
SUPPORT+ @Q&A
Contact Us
Eng
繁
簡
Eng
繁
簡
A
A
A
Download App
0
My Profile
Profile
Health Record
Symptom Diary
Calendar
Trend
Contact Nurse
Login
Home
>
Tips and Resources
>
Patient Support Programmes
Patient Support Programmes
Please select
Bladder cancer
Bone cancer
Breast cancer
Cervical cancer
Colorectal cancer
Endometrial cancer
Esophageal cancer
Gastroentero- pancreatic neuroendocrine tumor (GEP-NETs)
Gastrointestinal stromal tumor (GIST)
Glioblastoma multiforme (GBM)
Glioma
Head and neck cancer
Kidney cancer
Leukemia
Liver cancer
Lung cancer
Lymphoma
Mesothelioma
Myeloma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Skin cancer
Solid tumor
Stomach cancer
Thyroid cancer
Urothelial cancer
Results
Please refer to website for latest information
Hospital Authority = HA
Avelumab
Pembrolizumab
Advanced
Public
Denosumab
Advanced
Public
Abemaciclib
Abemaciclib
Abemaciclib
Abemaciclib
Alpelisib
Atezolizumab
Everolimus
Lapatinib
Neratinib
Neratinib
Olaparib
Olaparib
Palbociclib
Palbociclib
Pembrolizumab
Pembrolizumab
Pembrolizumab
Pertuzumab & Trastuzumab
Pertuzumab & Trastuzumab
Pertuzumab & Trastuzumab
Pertuzumab & Trastuzumab
Pertuzumab & Trastuzumab (subcutaneous)
Pertuzumab & Trastuzumab (subcutaneous)
Pertuzumab & Trastuzumab (subcutaneous)
Pertuzumab & Trastuzumab (subcutaneous)
Ribociclib
Sacituzumab Govitecan
Talazoparib
Talazoparib
Trastuzumab (IV / SC)
Trastuzumab (Intravenous / Subcutaneous)
Trastuzumab Deruxtecan
Trastuzumab Deruxtecan
Trastuzumab Emtansine (T-DM1)
Trastuzumab Emtansine (T-DM1)
Trastuzumab Emtansine (T-DM1)
Trastuzumab Emtansine (T-DM1)
Stage I-III
Advanced
Public
Private
Bevacizumab
Pembrolizumab
Advanced
Public
Bevacizumab
Bevacizumab (biosimilar)
Cetuximab
Nivolumab
Panitumamab
Pembrolizumab
Ramucirumab
Regorafenib
Trifluridine and Tipiracil tablet
Advanced
Public
Dostarlimab
Lenvatinib
Lenvatinib & Pembrolizumab
Pembrolizumab
Advanced
Public
Private
Nivolumab
Nivolumab
Pembrolizumab
Stage I-III
Advanced
Public
Lutetium (177Lu) oxodotreotide
Advanced
Public
Imatinib
Regorafenib
Sunitinib
Advanced
Public
Bevacizumab
Tumor Treating Fields (TTF) Therapy
Tumor Treating Fields (TTF) therapy
Advanced
Public
Private
Temozolomide
Advanced
Public
Cetuximab
Nivolumab
Pembrolizumab
Advanced
Public
Axitinib
Lenvatinib
Nivolumab
Nivolumab & Ipilimumab
Pazopanib
Pembrolizumab
Sunitinib
Advanced
Public
Private
Acalabrutinib
Acalabrutinib
Azacitidine
Bendamustine
Dasatinib
Gemtuzumab Ozogamicin
Gilteritinib
Ibrutinib
Imatinib
Inotuzumab Ozogamicin
Midostaurin
Nilotinib
Obinutuzumab
Ponatinib
Rituximab
Venetoclax + Azacitidine
Advanced
Public
Private
Atezolizumab & Bevacizumab
Atezolizumab & Bevacizumab
Lenvatinib
Ramucirumab
Regorafenib
Sorafenib
Advanced
Public
Private
Afatinib
Alectinib
Amivantamab
Atezolizumab
Atezolizumab
Atezolizumab & Bevacizumab
Brigatinib
Capmatinib
Ceritinib
Crizotinib
Crizotinib
Dabrafenib & Trametinib
Dacomitinib
Durvalumab
Durvalumab
Entrectinib
Gefitinib
Lorlatinib
Nivolumab
Nivolumab
Nivolumab & Ipilimumab
Osimertinib
Osimertinib
Osimertinib
Osimertinib
Pembrolizumab
Ramucirumab
Sotorasib
Tepotinib
Stage I-III
Advanced
Public
Private
Acalabrutinib
Brentuximab Vedotin
Glofitamab & Obinutuzumab
Ibrutinib
Nivolumab
Obinutuzumab
Pembrolizumab
Plerixafor
Polatuzumab Vedotin
Rituximab
Zanubrutinib
Advanced
Public
Nivolumab & Ipilimumab
Tumor Treating Fields (TTF) Therapy
Tumor Treating Fields (TTF) Therapy
Advanced
Public
Private
Bortezomib
Carfilzomib
Daratumumab
Isatuximab & Pomalidomide
Ixazomib
Lenalidomide
Plerixafor
Pomalidomide
Advanced
Public
Bevacizumab
Niraparib
Olaparib
Olaparib
Pegylated Liposomal Doxorubicin
Advanced
Public
Private
Paclitaxel (Albumin)
Advanced
Public
Abiraterone acetate
Apalutamide
Enzalutamide
Enzalutamide
Olaparib
Stage I-III
Advanced
Public
Dabrafenib & Trametinib
Dabrafenib & Trametinib
Nivolumab
Nivolumab
Pembrolizumab
Pembrolizumab
Vemurafenib
Stage I-III
Advanced
Public
Entrectinib
Pembrolizumab
Advanced
Public
Nivolumab
Ramucirumab
Trastuzumab
Trastuzumab Deruxtecan
Trifluridine and Tipiracil tablet
Advanced
Public
Lenvatinib
Advanced
Public
Erdafitinib
Nivolumab
Nivolumab
Pembrolizumab
Stage I-III
Advanced
Public
{{INDICATION}}
{{FUNDINGSOURCES}}
{{PHONE}}
Funding Details
x
{{FUNDDETAIL}}